(1r,4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexanol dihydrochloride
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

(1r,4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexanol dihydrochloride

● In Stock

Catalogue No.:VE009529
CAS No.:N/A
Mol. Formula:C13H21BrCl2N2O
Mol. Weight:372.13 g/mol

Additional information on (1r | 4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexanol dihydrochloride

Parent drug

Dapagliflozin

IUPAC Name

(1r, 4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexanol dihydrochloride

Synonyms

N/A

Description

(1r,4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexanol dihydrochloride Or (1r,4r)-4-((2-amino-4-bromobenzyl)amino)cyclohexanol dihydrochloride, It is an impurity of Dapagliflozin. Dapagliflozin is highly potent, is a reversible and selective sodium-glucose cotransporter-2 inhibitor, and is indicated for the treatment of type 2 diabetes. also, Dapagliflozin reduced the rate of cardiovascular death or hospitalization for heart failure.

References

Dhillon, S. (2019). Dapagliflozin: A Review in Type 2 Diabetes. Drugs, 79(10), 1135–1146. https://doi.org/10.1007/s40265-019-01148-3

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url